Quipt Home Medical Corp.(QIPT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,958 of 2,856 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
QIPT Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Quipt Home Medical Corp. (QIPT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores QIPT at 41.4/100 on a 32-signal composite quality model, placing it at rank #1,958 of 2,856 stocks — the bottom half of the AI-ranked universe. QIPT scores in the top quartile across earnings quality (90.7). Areas of concern include revenue scale (21.2) and profitability (23.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 44.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2025), Quipt Home Medical Corp. reports quarterly revenue of $81.0M, net income of $-1.1M, an operating margin of 1.3%. Top institutional holders of QIPT by reported 13-F value include Forager Capital Management, Claret Asset Management, GLAZER CAPITAL, based on the most recent SEC filings. QIPT trades on the Nasdaq exchange and files with the SEC under CIK 1540013. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QIPT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Quipt Home Medical Corp. directly from SEC EDGAR. Quipt Home Medical Corp.'s 13F Pro composite quality score has ranged between 27 and 50 since 2025, currently 41.4 — an improving long-term trajectory across 40 quarterly and live scoring snapshots.
Revenue
Q4 2025
$81.0M
Net Income
Q4 2025
$-1.1M
Free Cash Flow
Q4 2025
$6.9M
Operating Margin
Q4 2025
1.3%
ROIC
Q4 2025
2.1%
D/E Ratio
Q4 2025
0.74
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-0.2% YoYNet Income
-58.2% YoYOperating Income
-442.9% YoYEPS (Diluted)
-50.0% YoYTotal Assets
+14.6% YoYTotal Debt
+15.1% YoYOp. Cash Flow
+6.5% YoYFree Cash Flow
+1.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $245.4M -0.2% | $245.9M +16.2% | $211.7M +51.3% | $139.9M +36.6% | $102.4M +40.9% | $72.6M |
| Net Income | $-10.7M -58.2% | $-6.8M -142.9% | $-2.8M | — | — | — |
| Operating Income | $-3.8M -442.9% | $1.1M -60.9% | $2.9M | — | — | — |
| EPS (Diluted) | $-0.24 -50.0% | $-0.16 -128.6% | $-0.07 | — | — | — |
| Total Assets | $283.3M +14.6% | $247.2M -0.1% | $247.4M +87.1% | $132.2M +21.8% | $108.6M +50.7% | $72.1M |
| Total Debt | $87.6M +15.1% | $76.1M | — | — | — | — |
| Operating Cash Flow | $37.7M +6.5% | $35.4M -4.3% | $37.0M | — | — | — |
| Free Cash Flow | $25.3M +1.1% | $25.1M -16.8% | $30.1M | — | — | — |
Get alerted when QIPT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Quipt Home Medical Corp. including:
Top Institutional Holders of QIPT
Forager Capital Management, LLC
$14.8M4,199,562 shClaret Asset Management Corp
$11.4M3,225,309 shGLAZER CAPITAL, LLC
$6.9M1,958,918 shVANGUARD GROUP INC
$5.7M1,625,144 shARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$2.7M763,248 shGABELLI FUNDS LLC
$2.7M756,050 shGABELLI & Co INVESTMENT ADVISERS, INC.
$2.4M688,950 shGroupe la Francaise
$2.1M605,880 shMILLENNIUM MANAGEMENT LLC
$1.9M550,344 shPolar Asset Management Partners Inc.
$1.9M550,000 sh
| Fund | Value | Shares |
|---|---|---|
| Forager Capital Management, LLC | $14.8M | 4,199,562 |
| Claret Asset Management Corp | $11.4M | 3,225,309 |
| GLAZER CAPITAL, LLC | $6.9M | 1,958,918 |
| VANGUARD GROUP INC | $5.7M | 1,625,144 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $2.7M | 763,248 |
| GABELLI FUNDS LLC | $2.7M | 756,050 |
| GABELLI & Co INVESTMENT ADVISERS, INC. | $2.4M | 688,950 |
| Groupe la Francaise | $2.1M | 605,880 |
| MILLENNIUM MANAGEMENT LLC | $1.9M | 550,344 |
| Polar Asset Management Partners Inc. | $1.9M | 550,000 |
More Healthcare Companies
View all Healthcare →Put QIPT on your watchlist
Track score changes the day Quipt Home Medical Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is QIPT a good stock to buy?
13F Pro's AI-powered analysis of Quipt Home Medical Corp. (QIPT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for QIPT are available on the QIPT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. QIPT is classified as a small company.
Which hedge funds own QIPT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling QIPT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Quipt Home Medical Corp.'s investment landscape.